Cargando…
Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer’s Disease Drug Development
Alzheimer’s disease (AD) is a devastating neurodegenerative disease and the primary cause of dementia worldwide. Despite the magnitude of AD’s impact on patients, caregivers, and society, nearly all AD clinical trials fail. A potential contributor to this high rate of failure is that established cli...
Autores principales: | Bachman, Shelby L., Blankenship, Jennifer M., Busa, Michael, Serviente, Corinna, Lyden, Kate, Clay, Ieuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578291/ https://www.ncbi.nlm.nih.gov/pubmed/37545234 http://dx.doi.org/10.3233/JAD-230152 |
Ejemplares similares
-
Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior
por: Aryal, Suvekshya, et al.
Publicado: (2023) -
The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder
por: Peerenboom, Nele, et al.
Publicado: (2023) -
Capturing what matters: updating NICE methods guidance on measuring and valuing health
por: Dawoud, Dalia, et al.
Publicado: (2022) -
Reverse Engineering of Digital Measures: Inviting Patients to the Conversation
por: Clay, Ieuan, et al.
Publicado: (2023) -
Editorial: Multimodal digital approaches to personalized medicine
por: Clay, Ieuan, et al.
Publicado: (2023)